QuidelOrtho Receives FDA Clearance for QuickVue COVID-19 Test

Tuesday, 2 April 2024, 13:17

The FDA has granted QuidelOrtho 510(k) clearance for their QuickVue COVID-19 test, marking a significant milestone in the fight against the pandemic. The approval paves the way for expanded testing capabilities and increased accessibility to reliable diagnostic tools. QuidelOrtho's QuickVue test demonstrates the commitment to innovation and public health safety amidst the ongoing health crisis.
LivaRava Finance Meta Image
QuidelOrtho Receives FDA Clearance for QuickVue COVID-19 Test

QuidelOrtho Secures FDA Approval for QuickVue COVID-19 Test

QuidelOrtho has received FDA 510(k) clearance for its QuickVue COVID-19 test, a pivotal development in the company's ongoing efforts to combat the pandemic. This approval underscores the test's reliability and accuracy in diagnosing COVID-19 infections, providing healthcare professionals and the public with a valuable tool in the battle against the virus.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe